DARS1-AS1 and triple-negative breast carcinoma: When functioning as a molecular mediator, in triple-negative breast cancer 41, DARS-AS1 overexpression significantly upregulated the levels of TGF-β, p-Smad3, ATG5, and the conversion from LC3-I to LC3-II.